Elena Provaggi

Dr. Elena Provaggi


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
MGMichelle Gomes
Michelle Gomes
EPElena Provaggi
Elena Provaggi
APANDREA BARNABAS PEMBE
ANDREA BARNABAS PEMBE
AOAdeola Olaitan
Adeola Olaitan
AGAleksandra Gentry-Maharaj
Aleksandra Gentry-Maharaj
Cervical cancer causes 350,000 deaths annually, with 90% occurring in low- and middle-income countries (LMICs), despite being largely preventable through vaccination and screening. This review examines innovative approaches to address screening coverage gaps worldwide, analysing both established programmes in high-income countries and implementation strategies for LMICs. Self-sampling technologies demonstrate significant potential to improve the uptake of cervical screening, thereby improving cervical cancer prevention compared to traditional methods, particularly benefiting underserved populations across all healthcare settings. Among self-collection devices, vaginal brushes achieve sensitivity of 94.6% (95% CI: 92.4–96.8) for HPV detection, while novel approaches like the tampon show promising results (sensitivity 82.9–100%, specificity 91.6–96.8%) with high user acceptability. Implementation strategies vary by healthcare context, with high-income countries achieving success through integrated screening programmes and digital solutions, while LMICs demonstrate effective adaptation through community-based distribution (20–35% uptake) and innovative delivery methods. In resource-limited settings, self-sampling increases participation through enhanced patient comfort and cultural acceptability, while reducing costs by 32–48%. Progress toward WHO’s cervical cancer elimination goals require careful consideration of local healthcare infrastructure, cultural contexts and sustainable financing mechanisms. Future research priorities include optimising self-sampling technologies for sustainability and scalability, developing context-specific implementation strategies and validating artificial intelligence applications to enhance screening efficiency across diverse healthcare settings.

23 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MGMichelle Gomes
Michelle Gomes
EPElena Provaggi
Elena Provaggi
APANDREA BARNABAS PEMBE
ANDREA BARNABAS PEMBE
AOAdeola Olaitan
Adeola Olaitan
AGAleksandra Gentry-Maharaj
Aleksandra Gentry-Maharaj
Cervical cancer causes 350,000 deaths annually, with 90% occurring in low and middle-income countries (LMICs), despite being largely preventable through vaccination and screening. This review examines innovative approaches to address screening coverage gaps worldwide, analysing both established programs in high-income countries and implementation strategies for LMICs. Self-sampling technologies demonstrate significant potential to increase screening participation by 1.5 to 2.5 times compared to traditional methods, particularly benefiting underserved populations across all healthcare settings. Vaginal brushes achieve the highest sensitivity (94.6%, 95% CI: 92.4-96.8) for HPV detection, while novel approaches like tampon sampling show promising acceptability and performance metrics. Implementation strategies vary by healthcare context, with high-income countries achieving success through integrated screening programs and digital solutions, while LMICs demonstrate effective adaptation through community-based distribution (20-35% uptake) and innovative delivery methods. In resource-limited settings, self-sampling increases participation through enhanced patient comfort and cultural acceptability, while reducing costs by 32-48%. Progress toward the WHO's cervical cancer elimination goals require careful consideration of local healthcare infrastructure, cultural contexts, and sustainable financing mechanisms. Future research priorities include optimising self-sampling technologies for sustainability and scalability, developing context-specific implementation strategies, and validating artificial intelligence applications to enhance screening efficiency across diverse healthcare settings.